Concord Biotech Ltd (658823Z IN) listed in India on 18th Aug 23. Coming up for six-month lockup expiry on 7th Feb 24 are the firm’s pre-IPO shareholders, along with a portion of its promoters’ stake.
Boomeranged on Tue, 28 May 2024 10:28
Ontario is looking to raise US$56m from selling a 3.4% stake in Concord Biotech. The deal has a floor price of INR1,320/share, at a 8.5% discount to the stock's last close. Ontario's remaining stake will be locked up for 90 days, and Citi is the sole bookrunner.